HERTFORDSHIRE, England, and PITTSBURGH, May 18, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced four scientific abstracts from the Wixela™ Inhub™ ...
DEAR PEOPLE’S PHARMACY: My father has severe COPD. The doctors at the Department of Veterans Affairs hospital prescribed Wixela, in addition to several other inhalers. Soon, he began to notice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback